Access to Capital: Managing the Antitrust Risks Associated With Mergers and Affiliations
15 August 2013
As part of this session, we will discuss:
- Mergers and other affiliations as a common way for hospitals and health systems to access capital, and an overview of trends in this area
- The increasing scrutiny of hospital and health system mergers by regulators (FTC, principally, but also DOJ and state AGs)
- An overview of recent enforcement activity: What kinds of transactions are generating enforcement actions? What are the common threads?
- How to manage the antitrust review process
- The importance of engaging counsel and the role of protective privileges
- How to avoid the creation of deal-killing documents
- Hart-Scott-Rodino filing — when it is necessary and how to manage the process
- An assessment of the economic impact and early judgments on the likelihood of enforcement scrutiny
- What does a challenge (a second request, litigation, and so forth) look like?
- How to manage the cost and delays caused by regulatory review, and what to expect
Speakers
- Roger D. Strode, Moderator, Partner, Foley & Lardner LLP
- David W. Simon, Partner, Foley & Lardner LLP
- Alan D. Rutenberg, Partner, Foley & Lardner LLP
- Lawrence Wu, President, NERA Economic Consulting
The Access to Capital Web Conference Series provides participants with needed information in the most efficient manner possible — only a telephone line and Internet access are required to participate — allowing you to stay up-to-date with timely information from anywhere in the nation.
For more information, please visit Foley.com or contact Zulaikha Rahim at [email protected].
People
Related Insights
21 October 2024
Events
Legal Overview of the BIOSECURE Act
Foley special counsel John Strom is speaking in the Association for Accessible Medicine’s GRx+Biosims 2024 conference in a panel titled “Legal Overview of the BIOSECURE Act” on October 21.
04 October 2024
Innovative Technology Insights
Decoding California’s Recent Flurry of AI Laws
Governor Newsom signed over 18 AI-related bills into law during September, impacting numerous industries.
17 October 2024
Events
Top Compliance Considerations when Commercializing in the U.S.
Kyle Faget and Nathan "Nate" Beaver, co-chair of Foley's Medical Device and Equipment Area of Focus within the firm's Health Care & Life Sciences Sector, invite you to join us for a webinar on the compliance considerations you need to know when you are commercializing your medical device products in the U.S.